A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
Public ClinicalTrials.gov record NCT00642941. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor for the Treatment of Participants With Recurrent or Refractory Ewing's Sarcoma, Osteosarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas.
Study identification
- NCT ID
- NCT00642941
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 317 participants
Conditions and interventions
Conditions
Interventions
- RG1507 Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 17, 2007
- Primary completion
- Feb 18, 2014
- Completion
- Feb 18, 2014
- Last update posted
- Feb 2, 2021
2007 – 2014
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| UCLA School Of Medicine Mattel's Children's Hospital At UCLA; Division Of Hematology-Oncology | Los Angeles | California | 90095-1752 | — |
| Sarcoma Oncology Center | Santa Monica | California | 90403 | — |
| Stanford Comprehensive Cancer Center | Stanford | California | 94305 | — |
| Washington Cancer Institute; Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Kootenai Medical Center | Coeur d'Alene | Idaho | 83814 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| NIH/NCI | Bethesda | Maryland | 20892 | — |
| Massachusetts General Hospital; Dana Farber Partnes Cancer Center | Boston | Massachusetts | 02114 | — |
| Dana Farber Partners Can Ctr | Boston | Massachusetts | 02115-6084 | — |
| University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109 | — |
| Nebraska Methodist Hospital; Onc Hem West | Omaha | Nebraska | 68114 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | — |
| Albert Einstein College of Medical Pediatrics; Department of Pediatrics | The Bronx | New York | 10467 | — |
| Carolinas Hematology Oncology Associates; Investigational Drug Services - Pharmacy | Charlotte | North Carolina | 28203 | — |
| Oregon Health and Science University Cancer Institute | Portland | Oregon | 97239 | — |
| Pennsylvania Oncology Hema Asc | Philadelphia | Pennsylvania | 19106 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Texas Children's Cancer Center; Baylor College of Medicine | Houston | Texas | 77030 | — |
| University of Texas M.D. Anderson Cancer Center | Houston | Texas | 77030 | — |
| Huntsman Cancer Institute; Orthopedic Center | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00642941, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2021 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00642941 live on ClinicalTrials.gov.